We are live on ! Find out more
DRZID

DePrince Race & Zollo Inc (DRZ) Portfolio holdings

AUM $5.29B
1-Year Est. Return 20.14%
This Fund
S&P 500
This Quarter Est. Return
-6.13%
1 Year Est. Return
+20.14%
3 Year Est. Return
+36.34%
5 Year Est. Return
+39.16%
10 Year Est. Return
+157.08%
AUM
$7.4B
AUM Growth
-$1.12B
Cap. Flow
-$592M
Cap. Flow %
-8%
Top 10 Hldgs %
13.14%
Holding
336
New
39
Increased
75
Reduced
165
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$88.5M
2
PX
Praxair Inc
PX
+$71.2M
3
KO icon
Coca-Cola
KO
+$67.1M
4
WBA
Walgreens Boots Alliance
WBA
+$51.4M
5
FLO icon
Flowers Foods
FLO
+$49.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$100M
2
URS
URS CORP
URS
+$86.4M
3
NTRS icon
Northern Trust
NTRS
+$82M
4
BNY
Bank of New York Mellon
BNY
+$78.1M
5
KSS icon
Kohl's
KSS
+$62.7M

Sector Composition

Rank Sector Weight
1 Financials 23.45%
2 Consumer Discretionary 14.54%
3 Industrials 14.15%
4 Energy 10.59%
5 Technology 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRL
76
DELISTED
MICREL INC
MCRL
$43.8M 0.59%
3,637,350
+369,363
+11% +$4.32M
PPLI
77
People Inc
PPLI
$3.02B
$43.6M 0.59%
+3,698,564
New +$44.7M
OLN icon
78
Olin
OLN
$2.13B
$43.5M 0.59%
1,723,600
-137,400
-7% -$3.66M
IPCC
79
DELISTED
Infinity Property & Casualty C
IPCC
$43.5M 0.59%
679,421
-32,519
-5% -$2.17M
TECH icon
80
Bio-Techne
TECH
$11.3B
$43.3M 0.58%
1,850,064
-63,280
-3% -$1.48M
WABC icon
81
Westamerica Bancorp
WABC
$1.38B
$42.5M 0.57%
914,357
+105,197
+13% +$5.14M
DBD
82
DELISTED
Diebold Nixdorf Incorporated
DBD
$42.4M 0.57%
1,199,705
+460,660
+62% +$17.4M
ETN icon
83
Eaton
ETN
$179B
$42.1M 0.57%
+664,500
New +$47.1M
ETD icon
84
Ethan Allen Interiors
ETD
$575M
$41.8M 0.56%
1,832,600
+514,242
+39% +$12.5M
TROX icon
85
Tronox
TROX
$985M
$40.7M 0.55%
1,561,100
-195,550
-11% -$5.41M
LNCE
86
DELISTED
Snyders-Lance, Inc.
LNCE
$39.7M 0.54%
1,498,105
+112,081
+8% +$3.01M
CPA icon
87
Copa Holdings
CPA
$5.54B
$39.2M 0.53%
+365,500
New +$48.7M
BRKL
88
DELISTED
Brookline Bancorp
BRKL
$38.6M 0.52%
4,514,378
-254,202
-5% -$2.3M
MDT icon
89
Medtronic
MDT
$116B
$38M 0.51%
613,779
-38,300
-6% -$2.44M
SYT
90
DELISTED
Syngenta Ag
SYT
$37.9M 0.51%
597,539
+59,500
+11% +$4.21M
RRX icon
91
Regal Rexnord
RRX
$11.5B
$37.3M 0.5%
581,272
-16,347
-3% -$1.18M
PBF icon
92
PBF Energy
PBF
$8.34B
$36.6M 0.49%
1,525,912
+350,689
+30% +$9.24M
FFBC icon
93
First Financial Bancorp
FFBC
$3.58B
$36.1M 0.49%
2,279,969
-76,175
-3% -$1.26M
PRA
94
DELISTED
ProAssurance
PRA
$36.1M 0.49%
818,403
+5,600
+0.7% +$252K
SUSQ
95
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
$35.8M 0.48%
3,578,496
+700,388
+24% +$7.22M
NPBC
96
DELISTED
NATL PENN BANCSHARES INC
NPBC
$35.8M 0.48%
3,684,629
-116,340
-3% -$1.18M
ABM icon
97
ABM Industries
ABM
$2.84B
$35.5M 0.48%
1,383,588
-59,475
-4% -$1.56M
MDP
98
DELISTED
Meredith Corporation
MDP
$34.9M 0.47%
815,410
-28,455
-3% -$1.33M
MLKN icon
99
MillerKnoll
MLKN
$1.64B
$34.2M 0.46%
1,146,929
+374,593
+49% +$11.3M
RGP icon
100
Resources Connection
RGP
$144M
$34.1M 0.46%
2,443,457
-151,726
-6% -$2.23M

Similar funds

DePrince Race & Zollo Inc (DRZ)'s Q3 2014 Portfolio in Review

As of Q3 2014, DePrince Race & Zollo Inc (DRZ) held 336 positions worth $7.4B, down 13% from $8.52B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

DePrince Race & Zollo Inc (DRZ) withdrew a net $592M in Q3 2014, closing 54 positions and reducing 165 holdings. Its most notable exit was Amgen, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, DePrince Race & Zollo Inc (DRZ) opened a new position in Pfizer worth $88.5M.

  • DePrince Race & Zollo Inc (DRZ)'s largest Q3 2014 buy was Pfizer: 3,153,779 shares worth $88.5M.
  • DePrince Race & Zollo Inc (DRZ) added most to Emerson Electric in Q3 2014, an estimated $34.5M increase.
  • DePrince Race & Zollo Inc (DRZ)'s biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $44.4M.
  • DePrince Race & Zollo Inc (DRZ) fully exited Amgen in Q3 2014, selling an estimated $100M.
  • DePrince Race & Zollo Inc (DRZ)'s ten largest holdings make up 13% of its $7.4B portfolio in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ) opened 39 new positions and closed 54 in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ)'s portfolio value fell 13% quarter-over-quarter to $7.4B.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2014, filed 30 Oct 2014.